OMC
AGIO icon

Old Mission Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Old Mission Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-29,553
Closed -$1.63M – 959
2021
Q2 		$1.63M Buy
29,553
+16,298
+123% +$911K 0.06% 294
2021
Q1 		$684K Buy
+13,255
New +$656K 0.04% 444
2020
Q3 		– Sell
-12,843
Closed -$687K – 424
2020
Q2 		$687K Buy
+12,843
New +$595K 0.05% 238

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Old Mission Capital's AGIO Position: Q3 2021 in Review

Old Mission Capital sold out of Agios Pharmaceuticals (AGIO) in Q3 2021, closing a stake of 29,553 shares — an estimated $1.63M sold.

Old Mission Capital first reported a position in AGIO in Q2 2020 and held it in 3 quarters. The position peaked at $1.63M in Q2 2021. 164 funds tracked by Wall St. Rank hold AGIO as of Q3 2021.

  • Old Mission Capital reported no remaining Agios Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Old Mission Capital sold 29,553 Agios Pharmaceuticals shares in Q3 2021, an estimated $1.63M.
  • Old Mission Capital first reported a position in Agios Pharmaceuticals in Q2 2020 and held it in 3 quarters.
  • Old Mission Capital's Agios Pharmaceuticals position peaked at $1.63M in Q2 2021.
  • 164 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2021.

Based on Old Mission Capital's 13F filing for Q3 2021, filed 12 Nov 2021.